171 results on '"Growdon, W.B."'
Search Results
2. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer
3. Outcomes of minimally invasive versus open abdominal hysterectomy in patients with gestational trophoblastic disease
4. Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgery for vulvar cancer
5. A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancer
6. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
7. Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer
8. Neoadjuvant chemotherapy does not disproportionately benefit postoperative complication rates or time to chemotherapy in obese ovarian cancer patients
9. Ablation and ultrasonic aspiration: Adjunct surgical techniques at the time of primary debulking surgery to address advanced-stage, miliary-type ovarian, fallopian tube and primary peritoneal cancer
10. Black women disproportionately suffer throughout cancer treatment: Results from a prospective patient-reported outcomes program in gynecologic malignancy
11. A prospective, large-scale patient-reported outcomes program in patients with gynecologic malignancy
12. Neoadjuvant Chemotherapy Does Not Disproportionately Influence Post-operative Complication Rates or Time to Chemotherapy in Obese Patients with Advanced-stage Ovarian Cancer
13. Recurrence patterns after complete surgical resection for advanced-stage ovarian cancer: A comparison of primary and interval debulking surgery
14. Participation in ovarian cancer clinical trials is associated with improved overall survival
15. Complex immune checkpoint signatures in a subset of endometrial cancers
16. Clinical trial participation and measures of aggressive care at the end of life in patients with ovarian cancer
17. Intraperitoneal chemotherapy improves oncologic outcome in stage IIIC epithelial ovarian cancer patients with miliary subtype
18. Medical therapy for recurrent endometrial carcinoma following conventional platinum based cytotoxic chemotherapy
19. Choosing the right preoperative imaging: Prognostic value of PET-CT compared to CT for preoperative planning in high risk histology endometrial carcinoma
20. Impact of residual disease at interval debulking surgery on patterns of recurrence among patients with advanced-stage epithelial ovarian cancer
21. Perioperative blood transfusion impacts neither morbidity nor mortality in patients undergoing interval debulking surgery for advanced stage ovarian cancer
22. Improvement of radiological disease on CT after neoadjuvant chemotherapy may not correlate with chemotherapy response score (CRS) in advanced tubo-ovarian high-grade serous ovarian carcinoma
23. Site of residual disease does not predict recurrence patterns in epithelial ovarian cancer patients undergoing primary debulking surgery
24. RNA expression analysis of immune checkpoints in a subset of cervical cancers: A pilot study
25. Risk of unplanned postoperative readmission after sentinel lymph node biopsy compared to complete inguinofemoral lymphadenectomy in patients with squamous cell carcinoma of the vulva
26. Assessment of a scoring system to predict outcomes after interval debulking surgery for advanced ovarian carcinoma
27. Utilization of preoperative PET-CT and pelvic MRI reduces multimodality therapy in the care of women with early-stage cervical carcinoma
28. Decentralized treatment for post-molar gestational trophoblastic neoplasia (PMGTN) is associated with increased lines of chemotherapy and longer time to remission
29. Checkpoint inhibitor signatures across endometrial carcinoma histologic subtypes
30. A comparison of sentinel lymph node biopsy to lymphadenectomy for high-grade endometrial cancer staging
31. Elevated body mass index (BMI) is associated with a decreased risk of recurrence and increased administration of adjuvant radiation and chemotherapy
32. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low- and high-grade endometrial tumors
33. Laparoscopic interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer
34. Aborted upfront debulking does not reduce likelihood of optimal interval debulking compared with planned neoadjvuant chemotherapy
35. Fertility-conserving surgery among young women with stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base
36. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer
37. Timing of referral to the New England Trophoblastic Disease Center: Does referral with molar pregnancy versus postmolar gestational trophoblastic neoplasia affect outcomes?
38. Adjuvant hysterectomy for cervical cancer: Indications, complications, and outcomes
39. Racial disparities in incidence and survival of gynecologic sarcoma: An analysis of 19,797 women within the Surveillance, Epidemiology, and End Results database
40. Minimally invasive radical hysterectomy for cervical cancer reduces morbidity with similar outcomes compared with laparotomy
41. Next-generation genomic signature highlights sustained AKT and estrogen receptor signaling as key mediators of resistance following phosphatidylinositol 3-kinase (PI3K) inhibition in patient-derived xenograft models with and without PIK3CA gene mutations
42. Outcomes among women diagnosed with cervical cancer at the time of hysterectomy
43. Outcomes among patients with advanced-stage low-grade serous ovarian cancer: Analysis of the National Cancer Data Base, 2003-2011
44. Patient, treatment, and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer
45. Racial disparities in survival in malignant germ cell tumors of the ovary
46. Management of type II/high-grade endometrial cancer: A prospective cohort study utilizing a standard algorithm
47. Targeting HER2 and PI3K in Uterine Serous Cancer
48. Patient, Treatment and Discharge Factors associated with Hospital Readmission within 30days after Surgery for Vulvar Cancer
49. Abstract 13: Trends in treatment of uterine serous cancer in the medicare population
50. PI3K coupled to PARP inhibition demonstrates synergistic anti-tumor activity in endometrioid endometrial cancer patient derived xenografts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.